Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Part of paid clinical trials in Burlington, Vermont.

Sponsor
University of Vermont
Study ID
NCT06670079
Status
Recruiting

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Prolonged exposure therapy + incentives for therapy session attendance — BEHAVIORAL
    Prolonged exposure therapy plus incentives for therapy session attendance

Study Details

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning. Participants will: * Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

Key Dates

Start date
Feb 5, 2026
Status verified
May 2026
Primary completion
Jul 15, 2027
Completion
Jul 22, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Prolonged exposure therapy + incentives for therapy session attendance

Primary Outcome Measure

Change in Posttraumatic Stress Disorder Symptom Severity - Clinician Rated [ Time Frame: From baseline to the 12-week assessment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of VermontBurlingtonVermont05401
Kelly Peck
8026569610

Find similar trials in Burlington, VT

Related Studies